Obesity and coronary artery calcium in diabetes: The coronary artery calcification in type 1 diabetes (CACTI) study

Diabetes Technology and Therapeutics

Volumn 13, Issue 10, 2011, Pages 991-996

  Rodrigues, Ticiana C ^a,b   Veyna, Adrienne M ^a   Haarhues, Michelle D ^a   Kinney, Gregory L ^a   Rewers, Marian ^a,c   Snell Bergeon, Janet K ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c Global Health and Health Disparities   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CALCIUM; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM;

ADULT; BODY MASS INDEX; CALCINOSIS; CALCIUM; COHORT STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 80053392991     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0046     Document Type: Article

References (22)

1. Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD: Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure. JAMA 1998;280:140-146. (Pubitemid 28498385)
2. Kilpatrick ES, Rigby AS, Atkin SL: Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care 2007;30:707-712.
3. Pambianco G, Costacou T, Orchard TJ: The prediction of major outcomes of type 1 diabetes: A 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care 2007;30:1248-1254. (Pubitemid 46684655)
4. Laakso M, Pyorala K: Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulindependent diabetes. Metabolism 1990;39:117-122. (Pubitemid 20053267)
5. Arai K, Yokoyama H, Okuguchi F, Yamazaki K, Takagi H, Hirao K, Kobayashi M; Japan Diabetes Clinical Data Management Study Group: Association between body mass index and core components of metabolic syndrome in 1486 patients with type 1 diabetes mellitus in Japan (JDDM 13). Endocr J 2008;55:1025-1032.
6. Carlson MG, Campbell PJ: Impact of obesity on insulin action in NIDDM. Diabetes 1993;52:2623-2629.
7. Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Hokanson JE, Brunzell JD: Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial. Diabetes 2003;52:2623-2629. (Pubitemid 37210553)
8. Marroquin OC, Kip KE, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE: Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the Women's Ischemia Syndrome Evaluation. Circulation 2004;109:706-713. (Pubitemid 38222888)
9. St-Pierre AC, Cantin B, Mauriége P, Bergeron J, Dagenais GR, Després JP, Lamarche B: Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005;172:1301-1305. (Pubitemid 40745071)
10. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
11. Dabelea D, Kinney G, Snell-Bergeon JK, Hokanson JE, Eckel RH, Ehrlich J, Garg S, Hamman RF, Rewers M; Coronary Artery Calcification in Type 1 Diabetes Study: Effect of type 1 diabetes on the gender difference in coronary artery calcification: A role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes 2003;52:2833-2839. (Pubitemid 37339714)
12. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ: Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 2000;49:626-632. (Pubitemid 30183752)
13. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832. (Pubitemid 20101575)
14. Hokanson JE, MacKenzie T, Kinney G, Snell-Bergeon JK, Dabelea D, Ehrlich J, Eckel RH, Rewers M: Evaluating changes in coronary artery calcium: An analytic method that accounts for interscan variability. AJR Am J Roentgenol 2004;182:1327-1332. (Pubitemid 38525535)
15. Thorn LM, Forsblom C, Wadén J, Saraheimo M, Tolonen N, Hietala K, Groop PH; Finnish Diabetic Nephropathy (Finn- Diane) Study Group: The metabolic syndrome as a risk factor for cardiovascular disease, mortality, and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 2009;32:950-952.
16. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004; 291:2847-2850. (Pubitemid 38747805)
17. Kip KE, Marroquin OC, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE; Women's Ischemia Syndrome Evaluation Investigators: Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation 2004;109:706-713. (Pubitemid 38222888)
18. Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN: The importance of waist circumference in the definition of metabolic syndrome: Prospective analyses of mortality in men. Diabetes Care 2006;29:404-409. (Pubitemid 44106526)
19. Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM: Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the Diabetes Control and Complications Trial. Circulation 2005;111:2446-2453. (Pubitemid 40696132)
20. Hayaishi-Okano R, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S, Kuroda A, Matsuhisa M, Kosugi K, Nishikawa N, Kajimoto Y, Hori M: Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002;25:1432-1438. (Pubitemid 41071157)
21. Kilpatrick ES, Keevil BG, Jagger C, Spooner RJ, Small M: Determinants of raised C-reactive protein concentration in type 1 diabetes. QJM 2000;93:231-236. (Pubitemid 30198960)
22. Costacou T, Edmundowicz D, Prince C, Conway B, Orchard TJ: Progression of coronary artery calcium in type 1 diabetes mellitus. Am J Cardiol 2007;100:1543-1547. (Pubitemid 350050857)